Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10968278
SERIAL NO

15342833

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SANOFI BIOTECHNOLOGY; REGENERON PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buggage, Ronald Paris, FR 3 1
Chu, Karen W White Plains, US 14 77
Corp, dit Genti Valérie Buisson, FR 2 1
Erickson, Kristine A Roxbury, US 5 37
Mery-Mignard, Dominique Montgeron, FR 2 1
Sridhara, Sundaram Preethi Aavali Belle Mead, US 2 1
Varona, Rafael Paris, FR 2 1
Vitti, Robert L Old Tappan, US 11 61

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 6, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 6, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00